Plain-English translation of NCT07008456 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II trial testing a medication called APHD (dextrose beads combined with a gel) to see if it can help people with obesity lose weight. The study will compare two different doses of the medication against placebo (inactive) beads to determine which dose works best and is safest. About 102 people will participate.
Many people struggle to lose weight through diet alone, and there is a need for new treatments to help. This medication is being studied to see if it could be an effective option for people with obesity, especially those who also have related health conditions like high blood pressure or high cholesterol.
You likely qualify if…
You likely don't qualify if…
You will take the beads twice daily (either the active medication or placebo) combined with a gel, and you won't know which group you're in. You'll have regular visits to the clinic where researchers will check your weight, health, and any side effects. The study will measure whether the medication helps you lose weight compared to placebo and monitor your overall safety throughout the trial.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Georgia